Skip to content

A cohort study of therapeutic efficacy of central venous occlusive disease in maintenance hemodialysis patients

A cohort study of therapeutic efficacy of central venous occlusive disease in maintenance hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106883
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central venous occlusive disease

Interventions

Stent graft group:None
Bare bracket group:None
PTA group:None

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Hemodialysis patients aged >=18 years old and <85 years old; 2. Patients with a clear diagnosis of end-stage renal disease and mature arteriovenous fistula or mimic intravenous fistula; 3. Diagnosis of central venous lesion and clear intent to undergo endural treatment.

Exclusion criteria

Exclusion criteria: 1. Endocavitary treatment is central venous catheter; 2. Patients with incomplete baseline data; 3. Those with malignant or wasting diseases and a life expectancy of less than 6 months; 4. Those with obvious mental illness or mental disorders; 5. Those with uncured malignant tumors or requiring chemotherapy and radiotherapy; 6. Active systemic infection (tuberculosis, sepsis, or systemic fungal infection); 7. Expected to be unable to complete at least 12 months of follow-up, such as planned kidney transplantation, etc.;

Design outcomes

Primary

MeasureTime frame
Primary patency rate of target lesions at 12 months after surgery;

Secondary

MeasureTime frame
Cumulative patency of target lesions at 12 months postoperatively;Primary Patency Rates of Target Lesions at 24 Months Postoperatively;Cumulative Patency Rates of Target Lesions at 24 Months Postoperatively;

Countries

China

Contacts

Public ContactLihong Zhang

Beijing Haidian Hospital

zhanglihongzhu@163.com+86 135 2104 0707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026